The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Global Hereditary Testing Market Research Report 2024

Global Hereditary Testing Market Research Report 2024

Publishing Date : Feb, 2024

License Type :
 

Report Code : 1902913

No of Pages : 92

Ask Your Query
Synopsis
The mutation genetic material, including genetic mutations or chromosome aberration, is the source of genetic disease happen, is also different from other diseases of the basic characteristics.
The global Hereditary Testing market was valued at US$ 6347.5 million in 2023 and is anticipated to reach US$ 8715.4 million by 2030, witnessing a CAGR of 4.6% during the forecast period 2024-2030.
The Hereditary Testing market is a dynamic and rapidly growing sector within the broader genetic testing and healthcare industry. It involves the analysis of an individual's DNA to identify genetic variations associated with inherited diseases, traits, or susceptibilities. This type of testing provides valuable insights into an individual's genetic predispositions and can be used for various purposes, including disease risk assessment, ancestry tracing, and personalized medical treatment. The Hereditary Testing market has expanded significantly due to the growing interest in understanding one's genetic heritage and assessing genetic health risks. Leading genetic testing companies such as 23andMe, AncestryDNA, and MyHeritage offer direct-to-consumer hereditary testing kits, making genetic insights more accessible to the public. Additionally, healthcare providers and laboratories offer hereditary testing for clinical and medical purposes. As genetic information continues to play an increasingly essential role in healthcare decision-making and personalized medicine, the Hereditary Testing market is poised to remain at the forefront of advancements in genetic science and health management.
This report aims to provide a comprehensive presentation of the global market for Hereditary Testing, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Hereditary Testing.
Report Scope
The Hereditary Testing market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Hereditary Testing market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Hereditary Testing companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Myriad Genetics, Inc.
Invitae Corporation
Illumina, Inc.
Natera, Inc.
Laboratory Corporation of America Holdings
F. Hoffmann-La Roche Ltd
Quest Diagnostics Incorporated
CooperSurgical, Inc.
Agilent Technologies, Inc.
Thermo Fisher Scientific, Inc.
Twist Bioscience
Sophia Genetics
Fulgent Genetic, Inc.
Medgenome
CENTOGENE
23andMe
AncestryDNA
MyHeritage
Segment by Type
Hereditary Cancer Testing
Hereditary Non-cancer Testing
Segment by Application
Hospital
Clinic
Laboratory
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Hereditary Testing companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Hereditary Testing Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Hereditary Cancer Testing
1.2.3 Hereditary Non-cancer Testing
1.3 Market by Application
1.3.1 Global Hereditary Testing Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Laboratory
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Hereditary Testing Market Perspective (2019-2030)
2.2 Hereditary Testing Growth Trends by Region
2.2.1 Global Hereditary Testing Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Hereditary Testing Historic Market Size by Region (2019-2024)
2.2.3 Hereditary Testing Forecasted Market Size by Region (2025-2030)
2.3 Hereditary Testing Market Dynamics
2.3.1 Hereditary Testing Industry Trends
2.3.2 Hereditary Testing Market Drivers
2.3.3 Hereditary Testing Market Challenges
2.3.4 Hereditary Testing Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Hereditary Testing Players by Revenue
3.1.1 Global Top Hereditary Testing Players by Revenue (2019-2024)
3.1.2 Global Hereditary Testing Revenue Market Share by Players (2019-2024)
3.2 Global Hereditary Testing Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Hereditary Testing Revenue
3.4 Global Hereditary Testing Market Concentration Ratio
3.4.1 Global Hereditary Testing Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Hereditary Testing Revenue in 2023
3.5 Hereditary Testing Key Players Head office and Area Served
3.6 Key Players Hereditary Testing Product Solution and Service
3.7 Date of Enter into Hereditary Testing Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Hereditary Testing Breakdown Data by Type
4.1 Global Hereditary Testing Historic Market Size by Type (2019-2024)
4.2 Global Hereditary Testing Forecasted Market Size by Type (2025-2030)
5 Hereditary Testing Breakdown Data by Application
5.1 Global Hereditary Testing Historic Market Size by Application (2019-2024)
5.2 Global Hereditary Testing Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Hereditary Testing Market Size (2019-2030)
6.2 North America Hereditary Testing Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Hereditary Testing Market Size by Country (2019-2024)
6.4 North America Hereditary Testing Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Hereditary Testing Market Size (2019-2030)
7.2 Europe Hereditary Testing Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Hereditary Testing Market Size by Country (2019-2024)
7.4 Europe Hereditary Testing Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Hereditary Testing Market Size (2019-2030)
8.2 Asia-Pacific Hereditary Testing Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Hereditary Testing Market Size by Region (2019-2024)
8.4 Asia-Pacific Hereditary Testing Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Hereditary Testing Market Size (2019-2030)
9.2 Latin America Hereditary Testing Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Hereditary Testing Market Size by Country (2019-2024)
9.4 Latin America Hereditary Testing Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Hereditary Testing Market Size (2019-2030)
10.2 Middle East & Africa Hereditary Testing Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Hereditary Testing Market Size by Country (2019-2024)
10.4 Middle East & Africa Hereditary Testing Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Myriad Genetics, Inc.
11.1.1 Myriad Genetics, Inc. Company Detail
11.1.2 Myriad Genetics, Inc. Business Overview
11.1.3 Myriad Genetics, Inc. Hereditary Testing Introduction
11.1.4 Myriad Genetics, Inc. Revenue in Hereditary Testing Business (2019-2024)
11.1.5 Myriad Genetics, Inc. Recent Development
11.2 Invitae Corporation
11.2.1 Invitae Corporation Company Detail
11.2.2 Invitae Corporation Business Overview
11.2.3 Invitae Corporation Hereditary Testing Introduction
11.2.4 Invitae Corporation Revenue in Hereditary Testing Business (2019-2024)
11.2.5 Invitae Corporation Recent Development
11.3 Illumina, Inc.
11.3.1 Illumina, Inc. Company Detail
11.3.2 Illumina, Inc. Business Overview
11.3.3 Illumina, Inc. Hereditary Testing Introduction
11.3.4 Illumina, Inc. Revenue in Hereditary Testing Business (2019-2024)
11.3.5 Illumina, Inc. Recent Development
11.4 Natera, Inc.
11.4.1 Natera, Inc. Company Detail
11.4.2 Natera, Inc. Business Overview
11.4.3 Natera, Inc. Hereditary Testing Introduction
11.4.4 Natera, Inc. Revenue in Hereditary Testing Business (2019-2024)
11.4.5 Natera, Inc. Recent Development
11.5 Laboratory Corporation of America Holdings
11.5.1 Laboratory Corporation of America Holdings Company Detail
11.5.2 Laboratory Corporation of America Holdings Business Overview
11.5.3 Laboratory Corporation of America Holdings Hereditary Testing Introduction
11.5.4 Laboratory Corporation of America Holdings Revenue in Hereditary Testing Business (2019-2024)
11.5.5 Laboratory Corporation of America Holdings Recent Development
11.6 F. Hoffmann-La Roche Ltd
11.6.1 F. Hoffmann-La Roche Ltd Company Detail
11.6.2 F. Hoffmann-La Roche Ltd Business Overview
11.6.3 F. Hoffmann-La Roche Ltd Hereditary Testing Introduction
11.6.4 F. Hoffmann-La Roche Ltd Revenue in Hereditary Testing Business (2019-2024)
11.6.5 F. Hoffmann-La Roche Ltd Recent Development
11.7 Quest Diagnostics Incorporated
11.7.1 Quest Diagnostics Incorporated Company Detail
11.7.2 Quest Diagnostics Incorporated Business Overview
11.7.3 Quest Diagnostics Incorporated Hereditary Testing Introduction
11.7.4 Quest Diagnostics Incorporated Revenue in Hereditary Testing Business (2019-2024)
11.7.5 Quest Diagnostics Incorporated Recent Development
11.8 CooperSurgical, Inc.
11.8.1 CooperSurgical, Inc. Company Detail
11.8.2 CooperSurgical, Inc. Business Overview
11.8.3 CooperSurgical, Inc. Hereditary Testing Introduction
11.8.4 CooperSurgical, Inc. Revenue in Hereditary Testing Business (2019-2024)
11.8.5 CooperSurgical, Inc. Recent Development
11.9 Agilent Technologies, Inc.
11.9.1 Agilent Technologies, Inc. Company Detail
11.9.2 Agilent Technologies, Inc. Business Overview
11.9.3 Agilent Technologies, Inc. Hereditary Testing Introduction
11.9.4 Agilent Technologies, Inc. Revenue in Hereditary Testing Business (2019-2024)
11.9.5 Agilent Technologies, Inc. Recent Development
11.10 Thermo Fisher Scientific, Inc.
11.10.1 Thermo Fisher Scientific, Inc. Company Detail
11.10.2 Thermo Fisher Scientific, Inc. Business Overview
11.10.3 Thermo Fisher Scientific, Inc. Hereditary Testing Introduction
11.10.4 Thermo Fisher Scientific, Inc. Revenue in Hereditary Testing Business (2019-2024)
11.10.5 Thermo Fisher Scientific, Inc. Recent Development
11.11 Twist Bioscience
11.11.1 Twist Bioscience Company Detail
11.11.2 Twist Bioscience Business Overview
11.11.3 Twist Bioscience Hereditary Testing Introduction
11.11.4 Twist Bioscience Revenue in Hereditary Testing Business (2019-2024)
11.11.5 Twist Bioscience Recent Development
11.12 Sophia Genetics
11.12.1 Sophia Genetics Company Detail
11.12.2 Sophia Genetics Business Overview
11.12.3 Sophia Genetics Hereditary Testing Introduction
11.12.4 Sophia Genetics Revenue in Hereditary Testing Business (2019-2024)
11.12.5 Sophia Genetics Recent Development
11.13 Fulgent Genetic, Inc.
11.13.1 Fulgent Genetic, Inc. Company Detail
11.13.2 Fulgent Genetic, Inc. Business Overview
11.13.3 Fulgent Genetic, Inc. Hereditary Testing Introduction
11.13.4 Fulgent Genetic, Inc. Revenue in Hereditary Testing Business (2019-2024)
11.13.5 Fulgent Genetic, Inc. Recent Development
11.14 Medgenome
11.14.1 Medgenome Company Detail
11.14.2 Medgenome Business Overview
11.14.3 Medgenome Hereditary Testing Introduction
11.14.4 Medgenome Revenue in Hereditary Testing Business (2019-2024)
11.14.5 Medgenome Recent Development
11.15 CENTOGENE
11.15.1 CENTOGENE Company Detail
11.15.2 CENTOGENE Business Overview
11.15.3 CENTOGENE Hereditary Testing Introduction
11.15.4 CENTOGENE Revenue in Hereditary Testing Business (2019-2024)
11.15.5 CENTOGENE Recent Development
11.16 23andMe
11.16.1 23andMe Company Detail
11.16.2 23andMe Business Overview
11.16.3 23andMe Hereditary Testing Introduction
11.16.4 23andMe Revenue in Hereditary Testing Business (2019-2024)
11.16.5 23andMe Recent Development
11.17 AncestryDNA
11.17.1 AncestryDNA Company Detail
11.17.2 AncestryDNA Business Overview
11.17.3 AncestryDNA Hereditary Testing Introduction
11.17.4 AncestryDNA Revenue in Hereditary Testing Business (2019-2024)
11.17.5 AncestryDNA Recent Development
11.18 MyHeritage
11.18.1 MyHeritage Company Detail
11.18.2 MyHeritage Business Overview
11.18.3 MyHeritage Hereditary Testing Introduction
11.18.4 MyHeritage Revenue in Hereditary Testing Business (2019-2024)
11.18.5 MyHeritage Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

Published By : QY Research

Why ‘The Market Reports’

In Business: Pre Sales Support: Post Sales Support: Turn Around Time: Clients Served: Clients Assisted: Client Types: Payment: Partners with: Number of reports: Custom Research: Report Availability: Report Delivery Format: Security:

Payments Accepted From

Connect with us at

Complete Secure Website

SiteLock